• Mashup Score: 0

    October 17, 2023 — The Patel Children’s Heart Institute at St. Joseph’s Children’s Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.   “This accomplishment reflects the dedication of our entire congenital cardiac team,” said Interventional Cardiologist Dr. Jeremy Ringewald, who is the director of the Cardiac Catheterization Laboratory at St. Joseph’s Children’s Hospital. “Most importantly, this means that we allowed 250 patients in need of pulmonary or tricuspid valve replacement to avoid open-heart surgery.”  Tampa resident John Pino, 57, was the recipient of the 250th valve. He was born with pulmonary stenosis, a heart defect in which the pulmonary valve is narrowed and opens poorly. Pino underwent open-heart surgery when he was 9 years old to open up the narrowed valve, trading blockage for leakage. Eventually, the leakage led to enlargement of his heart and diminished exercise tolerance.  “When it was determined that I would need to

    Tweet Tweets with this article
    • @DAICeditor @StJoesChildren The #PatelChildren's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, #implanting its 250th congenital #transcatheter #heartvalve: https://t.co/2hbNrIiV3p

  • Mashup Score: 0

    October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not participate in recommended cardiac rehabilitation, a Michigan Medicine-led study finds. Researchers used clinical registry and health care claims data from over 3,300 patients who underwent transcatheter aortic valve replacement, or TAVR, in Michigan across 24 hospitals between 2016 and mid-2020, to determine the rate of cardiac rehabilitation participation and the factors associated with its utilization. Results published in JACC: Advances reveal that just 30.6% of patients who underwent TAVR participated in cardiac rehabilitation within 90 days after discharge. Patients who were older, more frail, smoked or had a history of common heart rhythm issues, like atrial fibrillation, were less likely to enter cardiac rehab. Whether a patient participated in the medically supervised exercise and educational program varied substantially across 24 hospitals, ranging from 5 to 60

    Tweet Tweets with this article
    • @DAICeditor @JACCJournals @umichCVC The vast majority of people who have a minimally invasive #heartvalve replacement procedure do not participate in recommended #cardiacrehabilitation, a #MichiganMedicine-led study finds: https://t.co/N2DfDcpKxG

  • Mashup Score: 0

    September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease recently became the first in the United States and the Western Hemisphere to repair a heart valve with severe tricuspid regurgitation in a patient using the investigational K-Clip Transvascular Tricuspid Repair System.  Pedro Engel Gonzalez, M.D., Brian O’Neill, M.D., and William O’Neill, M.D., performed the 60-minute, minimally invasive, nonsurgical procedure through a small incision in the patient’s neck with a  catheter to reach the failing heart and placed the K-Clip in a strategic target location around the dilated tricuspid valve.  Under the guidance of real-time 3D imaging and 4D modeling, the K-Clip system shrinks the diseased area around the tricuspid valve to help the patient’s valve to function better.    “The K-Clip system is an emerging technology and promising strategy for treating select patients with severe tricuspid regurgitation for whom traditional

    Tweet Tweets with this article
    • @DAICeditor @HenryFordHealth A team of #interventionalcardiologists became first in the US and Western Hemisphere to repair a #heartvalve with severe tricuspid regurgitation in a patient using investigational K-Clip #TransvascularTricuspidRepair System: https://t.co/24lFnxP7AG

  • Mashup Score: 0

    June 22, 2023 — Lankenau Medical Center, part of Main Line Health, has performed the first minimally invasive catheter-based procedure to treat aortic regurgitation in the Philadelphia region.  A cardiac team led by Basel Ramlawi, MD, chief of cardiothoracic surgery at Main Line Health, conducted the procedure in May as part of the JenaValve ALIGN-AR trial using an experimental Trilogy heart…

    Tweet Tweets with this article
    • @DAICeditor @mainlinehealth @LankenauCVSurg #Clinicaltrial establishes #Lankenau as one of the most comprehensive #heartvalve centers nationally by offering yet another alternative to #open_heart_surgery: https://t.co/Gt30MGHshy